But at least he was still fighting. The losses of Parkinson's disease differ for each patient and multiply and intensify over the years. Patients often live with it for decades.
Drugs can offer relief for years and then fail for a variety of reasons.
But Emory University researchers and clinicians are making strides toward finding long-term strategies to deal with this degenerative disease, which affects more than 1 million people in the United States alone. The NIH grant will fund five Emory studies over the next five years, giving neuroscientists here a chance to contribute even more to expanding knowledge about brain function. We have many extremely well-respected basic scientists and clinicians and a huge cadre of patients. Our surgeons are booked up months and months in advance. People come here from across the country and the world for Parkinson's treatment.